This is an excerpt from a post published by NaturalNews.com and is shared in accordance with fair use terms for nonprofit educational purposes.
In a statement, New York Attorney General Letitia James’ office said the agreement prohibits J&J from promoting opioids through any means. J&J is also now barred from lobbying the products at the federal, state or local level.
J&J stopped marketing its opioid products in the U.S. back in 2015, and as of 2020 has fully discontinued its business of selling them at all here in America.
Part of the settlement also forces J&J to resolve all opioids-related legal claims with allocated payments over the next nine years. The company could also be forced to pay $30 million more in the first year if the state’s executive chamber signs into law new legislation establishing an opioid settlement fund.
Opioid pharmaceuticals have killed at least 500,000 people in the United States over the past several decades. The settlement follows many years of lawsuits filed by states, cities and counties against opioid manufacturers like J&J.
Flagrant overprescribing of the drugs caused millions of Americans to become addicted. Many others became seriously injured or are now dead because of that addiction.
“The opioid epidemic has wreaked havoc on countless communities across New York state and the rest of the nation, leaving millions still addicted to dangerous and deadly opioids,” James indicated in a statement.
“Johnson & Johnson helped fuel this fire, but today they’re committing to leaving the opioid business – not only in New York, but across the entire country. Opioids will no longer be manufactured or sold in the United States by J&J.”
Author: Ethan Huff
Ethan Huff is an independent freelance journalist and NaturalNews.com Contributor. He writes about a wide range of topics including health and science. His posts have appeared in many media outlets including Natural News, Epoch Times, InfoWars, People’s Taliba, News Rescue, Australian National Review, and Ozarks Farm and Neighbor.